Xencor, Inc.

Stocks

Market Closed - Nasdaq Other stock markets 23:00:00 14/07/2026 +03			5-day change	1st Jan Change
14.95 ^USD	-0.07%		-4.59%	-2.35%

05-13	Xencor, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03:00 PM
05-06	Earnings Flash (XNCR) Xencor, Inc. Reports Q1 Revenue $4.5M	MT

Published on 05/05/2026 at 10:20 pm +03 - Modified on 06/19/2026 at 08:51 am +03

S&P Capital IQ

Presentation Operator Message
Operator (Operator)

Hello, and welcome to the Xencor DDW 2026 Webcast. [Operator Instructions] Also, reminder, this conference is being recorded today. If you have any

This article is reserved for subscribers

Unlock the article : SUBSCRIBE!

Already a customer? Log In

05-13	Xencor, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 03:00 PM
05-06	Earnings Flash (XNCR) Xencor, Inc. Reports Q1 Revenue $4.5M	MT
05-06	Xencor, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-05	Xencor, Inc. - Special Call
05-04	Xencor Inc Reports Final Results Of Phase 1 Study Of XmAb942 And Provides Update On XmAb412	CI
03-24	Xencor Shares Fall After JPMorgan Downgrade	MT
03-24	JPMorgan Downgrades Xencor to Neutral From Overweight, Adjusts PT to $13 From $18	MT
03-11	Xencor, Inc. Presents at Barclays 28th Annual Global Healthcare Conference, Mar-11-2026 11:30 AM
03-09	Xencor Inc Announces Termination Of Collaboration And License Agreement With Genentech Inc And F Hoffmann-La Roche Ltd	CI
02-26	Xencor files for mixed shelf	RE
02-26	Earnings Flash (XNCR) Xencor, Inc. Reports Q4 Revenue $28.2M, vs. FactSet Est of $30.0M	MT
02-26	Xencor, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
01-08	Xencor expects to have sufficient cash resources to fund research and development programs and operations through 2028	RE
01-08	Xencor Highlights Corporate Priorities and 2026 Pipeline Milestones	CI
12-17	Incyte Announces European Commission Approval of Minjuvi (Tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma	CI